Earnings
UBS stays positive on AstraZeneca ahead of second-quarter results
P
Proactive Investors
Published: Jul 13, 2026, 11:36 AM
Sentiment Analysis
Bullish0.70
BEARISHNEUTRALBULLISH
UBS maintains a positive outlook on AstraZeneca ahead of the company's second-quarter earnings report.
Sponsored
Source: Proactive Investors
This content is not intended as investment advice or a recommendation. Any opinions expressed are solely the personal views of each article.